Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α-reductase inhibitor
- Debra M. Sutkowski
- , James E. Audia
- , Robin L. Goode
- , Kenneth C. Hsiao
- , Ilan Y. Leibovitch
- , Ann M. McNulty
- , Blake Lee Neubauer*
*Corresponding author for this work
- Eli Lilly
- Indiana University-Purdue University Indianapolis
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations